Several nomograms are being developed to predict the future risk of having breast cancer, contralateral breast cancer or EOC in women with gBRCA mutations depending on several factors, one of them being the type of PV in BRCA1/2 gene. This evidence concerns the gene BRCA1 and breast cancer.